[Form 4] Tivic Health Systems, Inc. Insider Trading Activity
Michael K. Handley, Chief Operating Officer of Tivic Health Systems (TIVC), received an equity award. The Form 4 reports an employee stock option to purchase 45,000 shares of common stock with an exercise price of $3.32. The option was granted on 08/06/2025, is exercisable according to the stated vesting schedule and shows 45,000 underlying shares held directly after the grant. The option expires on 08/05/2035 and vests 50% on the first anniversary, with the remaining 50% in twelve equal quarterly installments so the award fully vests by year four.
Michael K. Handley, Chief Operating Officer di Tivic Health Systems (TIVC), ha ricevuto una concessione di equity. Il Form 4 segnala un'opzione azionaria per dipendenti per acquistare 45,000 azioni ordinarie con un prezzo di esercizio di $3.32. L'opzione 猫 stata concessa il 08/06/2025, 猫 esercitabile secondo il programma di vesting indicato e riporta 45,000 azioni sottostanti detenute direttamente dopo la concessione. L'opzione scade il 08/05/2035 e matura per il 50% al primo anniversario, con il restante 50% distribuito in dodici rate trimestrali uguali, in modo che la concessione sia completamente maturata entro il quarto anno.
Michael K. Handley, Director de Operaciones de Tivic Health Systems (TIVC), recibi贸 una adjudicaci贸n de capital. El Formulario 4 informa una opci贸n de compra para empleados de 45,000 acciones ordinarias con un precio de ejercicio de $3.32. La opci贸n fue otorgada el 08/06/2025, es ejercitable seg煤n el calendario de vesting indicado y muestra 45,000 acciones subyacentes mantenidas directamente despu茅s de la concesi贸n. La opci贸n vence el 08/05/2035 y consolida el 50% en el primer aniversario, con el 50% restante en doce pagos trimestrales iguales, de modo que la adjudicaci贸n queda totalmente consolidada al cuarto a帽o.
Michael K. Handley, Tivic Health Systems(TIVC)鞚� 斓滉碃鞖挫榿毂呾瀯鞛�(Chief Operating Officer)臧� 歆�攵� 氤挫儊鞚� 氚涭晿鞀惦媹雼�. Form 4電� 歆侅洂 鞀ろ啞鞓奠厴鞙茧 氤错喌欤� 45,000欤茧ゼ 旆摑頃� 靾� 鞛堧姅 鞓奠厴鞚� 頄夓偓臧�瓴� $3.32搿� 氤搓碃頃╇媹雼�. 頃措嫻 鞓奠厴鞚� 08/06/2025鞐� 攵�鞐悩鞐堦碃, 氇呾嫓霅� 氩犾姢韺�(vesting) 鞚检爼鞐� 霐半澕 頄夓偓 臧�電ロ晿氅� 攵�鞐� 歆來泟 45,000欤检潣 旮办磮欤检嫕鞚� 歆侅爲 氤挫湢頃橁碃 鞛堧姅 瓴冹溂搿� 響滌嫓霅╇媹雼�. 鞓奠厴 毵岆鞚检潃 08/05/2035鞚措┌, 1欤茧厔鞐愲姅 50%臧� 氩犾姢韸鸽悩瓿� 雮橂ǜ歆� 50%電� 12須岇潣 霃欖澕頃� 攵勱赴氤� 攵勴暊搿� 歆�旮夒悩鞏� 4雲勳皑鞐� 鞝勳暋 氩犾姢韸鸽惄雼堧嫟.
Michael K. Handley, directeur des op茅rations de Tivic Health Systems (TIVC), a re莽u une attribution d'equity. Le formulaire 4 signale une option d'achat pour employ茅s portant sur 45,000 actions ordinaires au prix d'exercice de $3.32. L'option a 茅t茅 accord茅e le 08/06/2025, est exer莽able selon le calendrier d'acquisition indiqu茅 et porte sur 45,000 actions sous-jacentes d茅tenues directement apr猫s l'attribution. L'option expire le 08/05/2035 et acquiert 50% au premier anniversaire, les 50% restants 茅tant r茅partis en douze versements trimestriels 茅gaux, de sorte que l'attribution est enti猫rement acquise 脿 la quatri猫me ann茅e.
Michael K. Handley, Chief Operating Officer von Tivic Health Systems (TIVC), erhielt eine Aktienzuteilung. Formular 4 meldet eine Mitarbeiteraktienoption zum Kauf von 45,000 Stammaktien zu einem Aus眉bungspreis von $3.32. Die Option wurde am 08/06/2025 gew盲hrt, ist gem盲脽 dem angegebenen Vesting鈥慫eitplan aus眉bbar und weist 45,000 zugrundeliegende Aktien aus, die unmittelbar nach der Gew盲hrung direkt gehalten werden. Die Option l盲uft am 08/05/2035 aus und vestet zu 50% am ersten Jahrestag; die 眉brigen 50% vesten in zw枚lf gleichen viertelj盲hrlichen Raten, sodass die Zuteilung nach vier Jahren vollst盲ndig vestet.
- Officer received an equity grant of 45,000 options, aligning management incentives with shareholders
- Vesting schedule is time-based (50% at first anniversary, remainder over 12 quarterly installments), supporting retention
- None.
Insights
TL;DR: A standard executive option grant aligns the COO with shareholders but raises routine reporting obligations.
The Form 4 documents an option award to the Chief Operating Officer for 45,000 shares at $3.32 per share, reported as a direct holding. The grant includes a common multi-year vesting schedule that ties pay to future service and potential share-price performance. From a governance perspective, this is a routine compensation action; disclosure is required and was provided. Absent other context on dilution or total outstanding equity, this single grant appears procedural rather than materially transformative.
TL;DR: The award is a typical retention/incentive instrument; materiality depends on company capitalization not included here.
The instrument is an employee stock option with a $3.32 exercise price and a ten-year term expiring 08/05/2035, covering 45,000 shares with a time-based vesting schedule (50% at year one, balance over 12 quarters). This structure is conventional for executive long-term incentives. Without details on total shares outstanding or prior grants, we cannot quantify dilution or cost, so the item should be treated as routine compensation disclosure rather than a major capital event.
Michael K. Handley, Chief Operating Officer di Tivic Health Systems (TIVC), ha ricevuto una concessione di equity. Il Form 4 segnala un'opzione azionaria per dipendenti per acquistare 45,000 azioni ordinarie con un prezzo di esercizio di $3.32. L'opzione 猫 stata concessa il 08/06/2025, 猫 esercitabile secondo il programma di vesting indicato e riporta 45,000 azioni sottostanti detenute direttamente dopo la concessione. L'opzione scade il 08/05/2035 e matura per il 50% al primo anniversario, con il restante 50% distribuito in dodici rate trimestrali uguali, in modo che la concessione sia completamente maturata entro il quarto anno.
Michael K. Handley, Director de Operaciones de Tivic Health Systems (TIVC), recibi贸 una adjudicaci贸n de capital. El Formulario 4 informa una opci贸n de compra para empleados de 45,000 acciones ordinarias con un precio de ejercicio de $3.32. La opci贸n fue otorgada el 08/06/2025, es ejercitable seg煤n el calendario de vesting indicado y muestra 45,000 acciones subyacentes mantenidas directamente despu茅s de la concesi贸n. La opci贸n vence el 08/05/2035 y consolida el 50% en el primer aniversario, con el 50% restante en doce pagos trimestrales iguales, de modo que la adjudicaci贸n queda totalmente consolidada al cuarto a帽o.
Michael K. Handley, Tivic Health Systems(TIVC)鞚� 斓滉碃鞖挫榿毂呾瀯鞛�(Chief Operating Officer)臧� 歆�攵� 氤挫儊鞚� 氚涭晿鞀惦媹雼�. Form 4電� 歆侅洂 鞀ろ啞鞓奠厴鞙茧 氤错喌欤� 45,000欤茧ゼ 旆摑頃� 靾� 鞛堧姅 鞓奠厴鞚� 頄夓偓臧�瓴� $3.32搿� 氤搓碃頃╇媹雼�. 頃措嫻 鞓奠厴鞚� 08/06/2025鞐� 攵�鞐悩鞐堦碃, 氇呾嫓霅� 氩犾姢韺�(vesting) 鞚检爼鞐� 霐半澕 頄夓偓 臧�電ロ晿氅� 攵�鞐� 歆來泟 45,000欤检潣 旮办磮欤检嫕鞚� 歆侅爲 氤挫湢頃橁碃 鞛堧姅 瓴冹溂搿� 響滌嫓霅╇媹雼�. 鞓奠厴 毵岆鞚检潃 08/05/2035鞚措┌, 1欤茧厔鞐愲姅 50%臧� 氩犾姢韸鸽悩瓿� 雮橂ǜ歆� 50%電� 12須岇潣 霃欖澕頃� 攵勱赴氤� 攵勴暊搿� 歆�旮夒悩鞏� 4雲勳皑鞐� 鞝勳暋 氩犾姢韸鸽惄雼堧嫟.
Michael K. Handley, directeur des op茅rations de Tivic Health Systems (TIVC), a re莽u une attribution d'equity. Le formulaire 4 signale une option d'achat pour employ茅s portant sur 45,000 actions ordinaires au prix d'exercice de $3.32. L'option a 茅t茅 accord茅e le 08/06/2025, est exer莽able selon le calendrier d'acquisition indiqu茅 et porte sur 45,000 actions sous-jacentes d茅tenues directement apr猫s l'attribution. L'option expire le 08/05/2035 et acquiert 50% au premier anniversaire, les 50% restants 茅tant r茅partis en douze versements trimestriels 茅gaux, de sorte que l'attribution est enti猫rement acquise 脿 la quatri猫me ann茅e.
Michael K. Handley, Chief Operating Officer von Tivic Health Systems (TIVC), erhielt eine Aktienzuteilung. Formular 4 meldet eine Mitarbeiteraktienoption zum Kauf von 45,000 Stammaktien zu einem Aus眉bungspreis von $3.32. Die Option wurde am 08/06/2025 gew盲hrt, ist gem盲脽 dem angegebenen Vesting鈥慫eitplan aus眉bbar und weist 45,000 zugrundeliegende Aktien aus, die unmittelbar nach der Gew盲hrung direkt gehalten werden. Die Option l盲uft am 08/05/2035 aus und vestet zu 50% am ersten Jahrestag; die 眉brigen 50% vesten in zw枚lf gleichen viertelj盲hrlichen Raten, sodass die Zuteilung nach vier Jahren vollst盲ndig vestet.
FAQ
What insider transaction did Michael K. Handley report for TIVC?
What is the vesting schedule for the TIVC option reported on Form 4?
When does the option for the TIVC grant expire?
How many shares underlying the derivative were reported and is ownership direct or indirect?
Who signed the Form 4 filing for this TIVC transaction?
